CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Providence Cancer Institute

Academic/Hospital

Also known as: Providence Cancer Institute | Rachel Sanborn

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Nov 1, 2004

Last known activity

May 31, 2020

Timeline

No events for the selected filters.

Drugs by trial phase (6 distinct, 3 trials)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (4)

  • NCT04364048Overall official - principal investigatorPhase 2May 31, 2020
  • NCT04364048Lead sponsorPhase 2May 31, 2020
  • NCT04116710Overall official - principal investigatorPhase 1Nov 30, 2019
  • NCT00150657Overall official - principal investigatorPhase 2Nov 1, 2004

Details

Last known activity
May 31, 2020